W. E. Donoghue & Co. LLC Takes $2.61 Million Position in Zoetis Inc (ZTS)
W. E. Donoghue & Co. LLC purchased a new position in shares of Zoetis Inc (NYSE:ZTS) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 36,201 shares of the company’s stock, valued at approximately $2,608,000.
Several other institutional investors and hedge funds have also modified their holdings of the company. Pittenger & Anderson Inc. grew its stake in shares of Zoetis by 20.6% during the 4th quarter. Pittenger & Anderson Inc. now owns 80,365 shares of the company’s stock worth $5,789,000 after acquiring an additional 13,700 shares in the last quarter. Edge Advisors LLC grew its stake in shares of Zoetis by 16,032.2% during the 4th quarter. Edge Advisors LLC now owns 9,518 shares of the company’s stock worth $684,000 after acquiring an additional 9,459 shares in the last quarter. WINTON GROUP Ltd bought a new position in shares of Zoetis during the 4th quarter worth approximately $339,000. Geode Capital Management LLC grew its stake in shares of Zoetis by 3.5% during the 4th quarter. Geode Capital Management LLC now owns 5,046,394 shares of the company’s stock worth $362,769,000 after acquiring an additional 169,228 shares in the last quarter. Finally, Icon Wealth Partners LLC bought a new position in shares of Zoetis during the 4th quarter worth approximately $127,000. 94.18% of the stock is owned by institutional investors.
In other Zoetis news, EVP Roxanne Lagano sold 35,663 shares of the firm’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $81.02, for a total transaction of $2,889,416.26. Following the completion of the sale, the executive vice president now owns 49,919 shares of the company’s stock, valued at approximately $4,044,437.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Heidi C. Chen sold 37,453 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $81.02, for a total value of $3,034,442.06. The disclosure for this sale can be found here. Insiders have sold a total of 97,001 shares of company stock valued at $7,882,428 in the last ninety days. Insiders own 0.31% of the company’s stock.
Shares of Zoetis Inc (ZTS) opened at $81.28 on Friday. Zoetis Inc has a twelve month low of $52.25 and a twelve month high of $83.46. The stock has a market capitalization of $39,033.81, a price-to-earnings ratio of 33.52, a price-to-earnings-growth ratio of 1.81 and a beta of 0.97. The company has a current ratio of 3.85, a quick ratio of 2.55 and a debt-to-equity ratio of 2.77.
Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 15th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.03. Zoetis had a return on equity of 65.96% and a net margin of 16.28%. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter last year, the firm posted $0.47 EPS. The company’s quarterly revenue was up 14.3% on a year-over-year basis. equities research analysts expect that Zoetis Inc will post 3.03 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be issued a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, April 19th. Zoetis’s dividend payout ratio is 28.57%.
ILLEGAL ACTIVITY NOTICE: “W. E. Donoghue & Co. LLC Takes $2.61 Million Position in Zoetis Inc (ZTS)” was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/w-e-donoghue-co-llc-takes-2-61-million-position-in-zoetis-inc-zts/1905110.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.